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Impairment, disability and fatigue in multiple sclerosis 
 
Abstract 
Background: Identifying the predictors of pain is important for both health professionals 
and researchers, because pain has repeatedly been found to be a strong predictor of activity 
limitations and participation restrictions. The objective of this study was to determine the 
predictors of pain presence and severity in a large, well-designed sample of community 
dwelling individuals with multiple sclerosis (MS). 
Methods: This was a cross-sectional study. A center-stratified random sample including 
188 persons with MS were recruited from three major MS clinics in the Greater Montreal, 
Canada. Main outcomes included pain prevalence and severity. Predictor variables 
included depression, anxiety, perceived health status, fatigue, sleep problems, and 
perceived cognitive deficits. Participants completed three questionnaires: the first asked 
about the socio-demographic and clinical information of the subjects, the second assessed 
the pain characteristics of the subjects, and the third covered the predictor variables. 
Results: The prevalence of pain in our sample was 42%. MS- related disability was found 
to be in the main predictor for both pain presence and intensity. Fatigue also was a main 
contributor to pain presence. The results of this study also showed that pain was associated 
with higher levels of depression, anxiety, sleep problems, and perceived cognitive deficits, 
and diminished perceived health status. 
Conclusions: The results of this study indicated that pain is a common symptom among 
people with MS. Pain presence was predicted by MS-related disability and fatigue, while 
pain intensity was only predicted by MS severity. 
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Multiple sclerosis (MS) is a chronic, inflammatory autoimmune demyelinating 
disease of the CNS. Pain is a frequent complaint among individuals with MS (1-6). The 
annual cost of MS has been estimated at 2.5 billion dollars in the US, and $502.3 million 
in Canada (6). The high prevalence of pain among persons with MS and the cost of MS 
pain would indicate that this is an important area of research in clinical management. 
There are several risk factors found to be associated with pain in people with MS such as 
older age, female sex, longer disease duration, and greater disease severity (5). While the 
relationship between pain and other factors in MS has been widely investigated, the 
relationship remains controversial and there is still inconsistency with respect to the 
important various clinical and personal factors (7). Identifying the predictors of pain is 
important for both health professional and researchers, because pain has repeatedly found 
to be a strong predictor of activity limitations and participation restrictions (2-4). Pain 
impacts on different aspects of individuals’ life. In comparison to MS people without pain 
and the general population, individuals with MS pain report poorer health-related quality 
of life (HRQL) (4), poorer overall mental and general health, more social role limitation, 
and more depressive symptoms (8-11). Moreover, nearly half of people with MS and pain 
report that pain interferes with their daily living activities (2) and sleep (12). 
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There are substantial gaps in the literature on pain in MS. 
Despite the high prevalence and significant impact, MS-
related pain is still poorly understood and often under-
emphasized because of its complexity and subjective nature. 
In addition, assessing pain is an essential component to 
rehabilitation, as it has been widely accepted that a first step 
in improving the treatment of pain is its adequate 
assessment. 
 Available information of MS related pain often is limited 
by value because of methodological and analytical problems. 
For the most part, previous studies have looked at pain as a 
uni-dimensional health outcome or have focused on only few 
dimensions of pain (e.g. intensity and duration) in their 
analysis.  
A comprehensive and detailed assessment of pain, along 
with its impact and predictors and its most related mediator 
variables such as those that have been provided in this study, 
as well as interpretation of results using appropriate 
statistical methods in a large and well methodologically 
designed study could improve our understanding of its nature 
and mechanism, and in turn contribute to the development of 
more targeted approaches to enhance pain management. 
Therefore, the objective of this study was to determine 
predictors of pain presence and intensity in a large, well-
designed sample of community dwelling individuals with 
MS. While the treatment of MS-related pain is challenging, 
knowledge of main contributors to pain can facilitate its 
prompt diagnosis and management. 
 
 
Methods 
Design: This was a cross-sectional study where the data 
were collected at a specific point in time from patients with 
MS, living in the Greater Montreal area, Canada. 
Participants: The target population for this study consisted 
of persons with a diagnosis of MS since 1995.  Patients with 
any clinical types of MS included: relapsing remitting (RR), 
primary progressive (PP), secondary progressive (SP), 
progressive relapsing (PR), and clinically isolated syndrome 
(CIS).  
The available population was all men and women who had 
been diagnosed since 1995 and registered at the three major 
MS clinics in the Greater Montreal including Montreal 
Neurological Hospital (MNH), Centre Hospitalier de 
l’Universite´ de Montreal (CHUM), and Clinique Neuro 
Rive-Sud (CNRS). A center-stratified random sample of 550 
individuals with MS was drawn, of which 364 were 
contacted. From those who were contacted, only the first 192 
who responded were only included, due to the limited 
budget. Following exclusion of three people with incomplete 
data and one person who did not attend the evaluation 
session, 139 women and 49 men comprised the study sample 
(52 % of those contacted). No significant difference was 
found between responders (n=188) and non responders 
(n=176) on age, sex, MS severity, date of diagnosis, and 
duration of symptoms. As is usual in the epidemiology of 
MS (1, 8), the sample consisted of more women than men 
(the ratio 2.8:1). Participants who had a relapse in the 
preceding month, participants younger than 18 years old, 
people with severe cognitive impairments, and those with 
pre existing health conditions affecting functioning, such as 
mental illness, heart disease, rheumatoid arthritis, 
malignancy, renal failure, HIV/Aids, or liver failure were 
excluded. 
Measures: All measures were chosen for the purpose of this 
study adequately representing the components of the 
underlying construct; their validity and reliability have been 
determined; and they have been used in MS researches in 
previous studies. 
Socio-demographic characteristics: Socio-demographic 
factors such as gender, age, smoking status, education level, 
and employment status were recorded on the day of testing 
using the socio-demographic questionnaire. 
Disease-related characteristics: The clinical records and 
medical charts of each participant were consulted to obtain 
data on MS type, and years since MS diagnosis and 
symptoms onset.  
Participants also were asked to report if they used disease 
modifying therapy (DMT). The severity of neurological 
impairment was scored by neurologists using the Expanded 
Disability Status Scale (EDSS), the standard measure for 
classification of MS related disability, ranging from 0 (no 
disability) to 10 (maximum disability) (13). 
Pain characteristics 
Pain prevalence: Patients were asked “Are you currently 
experiencing any pain regardless of intensity and 
localization?” Pain prevalence was determined by 
calculating the proportion of participants who answered 
‘yes’ to this question. Additional pain questions were only 
administered to persons with pain. 
Pain severity: To measure average, the lowest and worst 
pain severity over the previous week as well as pain at the 
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time of evaluation, we used 0–10 numeric rating scale 
(NRS), with 0 indicating ‘No pain’ and10 indicating ‘the 
most painful sensation imaginable’(14). NRS was also used 
to classify the participants as having no pain (score 0), mild 
pain (scores 1–4), moderate pain (scores 5- 6) and severe 
pain (scores 7–10) (15). Reliability, validity, and 
responsiveness of NRS have been documented (16, 17). 
Predictor variables 
Fatigue: Fatigue was measured using the 4-item vitality 
subscale (VIT) of the RAND-36, ranging from 0 to 100 with 
a higher score indicates greater energy/ lower level of fatigue 
(18). The vitality subscale of RAND-36 is part of the MS 
quality of life (MSQOL)-54 instrument which has been 
widely used in MS literature for assessing fatigue (19-21), 
and its psychometric properties have been provided (18).  
Sleep disturbance: To assess sleep disturbance, we used a 
specific sleep questionnaire created from Rasch Analysis of 
the Pittsburgh Sleep Quality Index (PSQI) (22) containing 4 
items that assess factors affecting sleep quality during the 
previous month. Total score ranges from 0 to 8, with a 
higher score indicating worse sleep quality during the 
previous month. Patients were also asked if their pain has 
interfered with their sleep during the last month.   
Perceived health status: Perceived health status was 
measured using the Euro-QOL visual analogue scale (EQ-
VAS) (23). Subjects were asked to rate their overall health 
on 0 to 100 VAS scale, with 0 showing the worst perceived 
health and 100 showing the best perceived health.  
Psychological well-being: The levels of psychological well-
being of participants were measured using the hospital 
anxiety and depression scale (HADS) (24). HADS has 14 
items, and the total score ranges between 0 and 21; higher 
scores indicate worse depression/ anxiety symptoms (24, 
25). The HADS is a reliable and valid tool and has been used 
in a number of MS studies (26, 27). 
Perceived cognitive impairment: Perceived cognitive 
impairment was assessed using the Perceived Deficits 
Questionnaire (PDQ) (28). The PDQ items assess frequency 
of difficulties with attention/concentration, memory, and 
planning/organization during the past month on a 5-point 
Likert scale. PDQ contains 20 items, each from 0 (never) to 
4 (almost always) with a maximum total score of 80; higher 
scores indicate greater perceived cognitive impairment (28). 
The validity and reliability of PDQ in MS has been widely 
accepted (28-30). 
Ethical considerations: Study protocol and procedures were 
approved by the ethics committee of each participating 
hospital, informed consent was obtained and signed by all 
subjects on the day of testing  
 
Statistical analysis 
Descriptive statistics (e.g, mean, standard deviations, and 
frequency) were used to describe the sample and 
summarized data. Associations between all variables were 
assessed using Spearman and Pearson correlation 
coefficients for categorical and continuous variables, 
respectively. Those variables that showed a significant 
relation with response variables (pain presence and severity) 
were considered as potential predictors in the regression 
analysis. The main outcomes of regression analysis were 
pain presence and severity. 
 As outcomes were not continuous variables, multiple 
logistic regressions were used to analyze data. We 
considered pain presence as a categorical variable i.e pain 
present or pain absent. So we ran a nominal logistic 
regression. For pain severity, we considered it as an ordinal 
variable (0 to 10), thus we ran an ordinal logistic regression.  
The personal and clinical characteristics of participants as 
well as the explanatory variables were included in the 
analysis. Using stepwise multiple regressions, each predictor 
variable was entered into the model, and retained or 
discarded based on their contribution to the overall model 
(statistical significance at the 0.05, beta estimate, odds ratio, 
and R squared). Sample size calculation was based on the 
rule of thumb for regression analysis that is a minimum of 10 
participants per predictor variable (31).  
Considering that in our final regression equations, there were 
9 predictors, a sample size of 188 participants would be 
suitable and adequate sample size for this study (21 persons 
per each variable). If there were participants with missing 
data, they were excluded from the analysis. Statistical 
significance was considered for p-values less than 0.05. 
Statistical analysis was performed using the Statistical 
Analysis Systems (SAS) Version 9.2. 
 
 
Results 
Socio- demographic and clinical characteristics of the 
sample: Socio- demographic and clinical characteristics of 
the sample are presented in table 1.  
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Table 1. Characteristics of study participants with a comparison of pain and pain free groups 
Variables Total  
(n=188 ) 
Pain group 
(n=78) 
Pain free group 
(n=110) 
P value
+ 
Current age ( ± SD) 43 ± 10 44 ± 10 42 ± 10 *0.6 
Gender, N (%)                                                                                                                                                   
           Women 139(74) 66 (35) 73(39) 
**0.04 
            Men 49(26) 15(8) 34(18) 
Education, N (%)    
***0.4 
   Primary school 2(1) 1(0.5) 1(0.5) 
   High school 41(22) 22(12) 19(10) 
   College 56(30) 23(12) 33(18) 
   University 85(46) 32(17) 53(29) 
   None 1(0.5) 0 1(0.5) 
Employment N (%)                                                                                                                                           
   Employed 119(64) 38(20) 81(44) 
**0.0002 
   unemployed 64(35) 39(21) 25(14) 
Smoking status, N (%)                                                                                                                                       
   Regularly  38(20) 20(11) 18(10) 
**0.3    Irregularly 10(5) 5(3) 5(3) 
   Non smoker  140(75) 56(30) 84(45) 
Years since diagnosis ( ±SD) 3±4 3±5 3±3.5 *0.9 
Years since symptom onset ( ± SD) 9±5 9±5 9±5 *0.9 
Disability, EDSS (Median± SD) 2.4±2 3±2 2±2 *0.0001 
DMT, N (%)      *0.6 
   Yes 110(85) 47(36) 63(49)  
   No 20(15) 10(7.5) (7.5)  
MS subtype, N (%)                                                                                                                                            
   Relapsing-Remitting 97(78) 43(35) 54(43) 
***0.03 
   Secondary progressive 7(5) 4(3) 3(2) 
   Primary progressive 8(7) 2(2) 6(5) 
   Primary relapsing 3(3) 2(2) 1(1) 
   Clinically isolated syndrome 9(7) 0 9(7) 
Pain impact     
Sleep disorders (PSQI: ± SD)   6.5±1.5 6.7±1.5 7.4±1.6 *0.4 
Perceived health status (EQ-VAS: ± SD)  73±17 66±19 78±13 *.0001 
Fatigue (VIT- RAND-36: ± SD)   49.5±20 41±20 56±19 *.0001 
Cognitive impairment (PDQ: ± SD) 24±15 29±14 20±14 *.0001 
Depression (HADS: ± SD) 4±4 5.3±4 3.4±4 *0.001 
Anxiety (HADS: ± SD) 5±4 6±4 4.6±3.6 *0.008 
±SD: mean± standard deviation             N: number           DMT: disease modifying therapy           PSQI: Pittsburgh Sleep QualityIndex 
PFI: physical function subscale of RAND-36             EQVAS: EuroQol visual analog scale        VITA: RAND-36 Vitality scale of RAND-36  
PDQ: Perceived Deficits Questionnaire              HADS: Hospital Anxiety and Depression Scale 
+ The p-values given in the last column represent the difference between the 'pain group' and 'pain free group'             * T-test; ** Chi square; *** Fisher test 
 
Pain characteristics of the sample: Of the 188 persons, 
42% identified pain as a symptom, and among those, 42% 
reported to have clinically significant pain (severity ≥4) at 
the time of evaluation.  The mean value for rating of current 
pain at the time of evaluation was 3.3±2.3; the mean of 
lowest pain severity was 2.2±2; the worst pain severity was 
6.8±2; and the pain average was 5.0±2. 40% of participants 
with pain reported that pain interfered with their sleep. In 
addition, participants without pain were more employed and 
reported greater energy level (lower fatigue), and daily living 
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activity in comparison to participants with pain (p<0.05). 
Participants without pain also tended to show less perceived 
cognitive impairments, depression, and anxiety (p<0.05) 
(table 1). Regarding sociodemographic and clinical 
characteristics, there was no difference between the 
participants with and without pain on age, education, and 
smoking status, DMT, and duration of symptoms onset and 
diagnosis (p>0.05). However, the pain group showed a 
higher women-to-men sex ratio (4:1 vs. 2:1 in pain group), 
and higher EDSS scores (table 1). 
Factors associated with presence and severity of pain in 
MS: The results of correlation analysis showed a statistically 
significant correlation between pain presence with gender, 
employment status, MS type, MS disability, fatigue, 
depression, anxiety, perceived health status, and perceived 
cognitive deficit (r = 0.1, r = -0.3, r = 0.2, r = 0.2, r = -0.34, r 
=0.2, r = 0.17, r = - 0.35, r = 0.3, p<0.05, respectively). MS- 
related disability, depression, and perceived health status 
also showed a statistically significant correlation with pain 
severity (r= 0.4, r= 0.3, r= -0.34, p<0.05, respectively). 
Nonetheless, no associations were observed in our study 
between pain severity with anxiety and perceived cognitive 
deficit. Neither pain presence, nor pain severity were 
associated with level of education, age, use of DMT, and 
years from symptom onset and diagnosis. 
Table 2 displays the results of regression analysis for 
response variables. The results of nominal logistic regression 
analysis for pain presence showed that only fatigue and MS-
related disability made a signiﬁcant contribution to 
prediction. Furthermore, analysis of maximum likelihood 
showed that for every unit change in fatigue score (RAND-
36, lower score means less vitality so more fatigue), the 
probability of pain presence decreases by 0.96 (p=0.0001). 
MS-related disability made also significant contribution to 
prediction as for a unit increase in MS severity, the 
probability of pain presence increased by 1.2 (p=0.03). The 
results of ordinal logistic regression on pain severity also 
indicated that only MS-related disability had a significant 
effect on pain severity (p=0.001). This means that for every 
unit increase in MS severity, (EDSS score, higher score is 
worse), the probability of experiencing more severe pain 
increases by 1.4. 
 
Table 2. Logistic regression model for pain presence and severity 
Parameter Parameter estimate Standard coefficient* P-value Odds ratio 
Pain presence     
Fatigue (RAND-36) -0.03 -0.6 0.0001 0.96 
MS-related disability (EDSS)             0.2 0.4 0.03 1.2 
Pain severity      
MS-related disability (EDSS)             0.4 0.8 0.001 1.4 
*Standardized coefficient = Parameter estimate x 1 Standard Deviation of each predictor 
 
Discussion 
The purpose of the present study was to determine the 
contributors to pain intensity and presence among people 
with MS. MS-related disability was found to be the main 
predictor for both pain presence and intensity. Fatigue also 
was a main contributor to pain presence. The results of 
comparisons between individuals with MS and pain and 
those who were pain-free showed that pain was associated 
with higher levels of depression, anxiety, sleep problems and 
cognitive deficit, and lower levels of general health  
perception, and ability to work. The prevalence of pain in 
our sample was 42%. In addition, participants’ ratings of 
their worst pain intensity showed that 60% of those patients 
with pain reported severe pain (7–10 out of 10). This finding  
indicates that despite low prevalence of pain, pain severity  
 
 
was high in our sample, therefore reinforcing the need to  
identify pain reasons and looking for an effective approach 
to treat it adequately. There was no significant difference in 
age between participants with pain those and without pain. 
Regression analysis also revealed that neither pain presence, 
nor pain severity was associated with age.  
 These findings are consistent with the results of several 
studies (3, 4, 8), and are in contrast with the results of 
Hadjimichael (12), and Svendsen (1). Additionally, our 
results show that gender was correlated neither with pain 
severity nor with the presence of pain. These findings are 
similar to Douglas (5), and are in contrast to Kalia (4). 
Moreover, the results of regression analysis revealed that 
neither the duration of diagnosis nor symptom onset has 
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been found to be associated with either pain presence or 
severity except for MS severity. These findings suggest that 
pain cannot be predicted solely based on the disease or 
personal characteristics and other factors play an important 
role. In accord with findings reported by previous studies (2, 
3, 12) results of our regression analysis revealed that MS-
related disability (measured by EDSS) was an important 
predictor for both pain presence and severity confirming that 
patients with greater disability are more likely to experience 
pain. Furthermore, similar to a previous study (2, 3, 8), we 
found that persons with pain were more likely to have 
greater MS disability than those without pain.  
Fatigue was found to contribute to pain presence in this 
study. This confirms the role of fatigue as the most disabling 
symptom of MS. In addition, these symptoms are possibly 
correlated through common etiology due to the simultaneous 
damage to nerve fibers across different parts of the CNS 
(32). Cognitive behavioral therapy (3), physical activity, 
rehabilitation programs, and energy conservation strategies 
have been shown to improve MS fatigue (34). 
Similar to results reported before (2-4, 8), patients 
with pain tended to be more depressed and anxious than 
those without pain. Nevertheless, our results did not show 
any predictor effect of depression on pain severity and 
presence. This can be partly related to the fact that our 
sample reported no serious depression symptom. The mean 
depression scores of our sample were 4 out of 21 on HADS; 
cut off point is 8. Additional research is needed to 
understand whether additional unique factors may mediate 
this relationship in individuals with MS. 
In agreement with Douglas (5), our results further 
revealed that persons reported more perceived cognitive 
deficit in the presence of pain. As Douglas (5) believes, this 
association can probably be related to the patients’ inabilities 
in coping strategies and problem-solving skills. Our finding 
further suggested that self-perceived health status could not 
act as a significant predictor for either pain severity or 
presence. Although, in agreement with other studies (2, 3), 
our results showed that participants with pain in comparison 
to those without pain were considerably more likely to report 
lower perceived health status. These findings encourage the 
implementation of specific approaches aimed at improving 
the self-perceived health status in people with MS.  
The current study has several strong points. It assessed a 
variety of MS symptoms using standardized measures which 
are used in MS population. Also, the study sample was 
randomly selected from 3 different clinics in Montreal from 
populations who were culturally diverse and living in 
different areas of the city. Besides, the sample included the 
whole range of disease severity, and type, consistent with a 
clinical spectrum of MS, so it could be representative of the 
general MS population. A further strength of this study was 
that, the present sample also  included many men, thus 
providing a unique opportunity to study MS and pain in both 
genders, whereas many studies on MS and pain have 
included only a few men participants. 
On the other hand, this study had several limitations. 
First, this was a cross-sectional study where subjects were 
assessed at one point in time, thus, the results do not show 
any cause and effect relation. Second, we purposely sampled 
individuals diagnosed after 1995. This was the year that 
DMT and magnetic resonance imaging (MRI) speeded the 
diagnosis and management of MS (35). Thus the results may 
not be generalized to all MS people who were diagnosed 
earlier. Third, as pain is a subjective experience, the scores 
could be subject to memory distortion, recall bias, and 
response shift. Finally, the fact that MS-related disability is a 
significant predictor of the presence and severity of pain 
invites caution when interpreting the associations between 
pain and employment status, perceived cognitive deficits, 
depression, anxiety, and perceived health status; all of these 
parameters are greatly influenced by MS-related disability. 
The results of this study help us to better predict the 
experience of pain among people with MS. Pain has 
repeatedly been found to be a strong predictor of activity 
limitation and participation restriction.  
The comparisons between participants with and without 
pain on job status in the current study also revealed an 
increasing proportion of participants not being employed in 
the presence of pain (63%). As MS is a disease that often 
affects young adults during their productivity years, this 
emphasizes the importance of early identification and 
treatment of pain. The identification of factors that diminish 
or trigger pain is important for clinicians, since it facilitates 
the development of targeted rehabilitative intervention to 
reduce pain. Research studies that compare the effects of 
pain on functioning in comparison to other MS symptoms 
are also necessary as their results would help clinicians to 
choose the priorities of treating these symptoms in persons 
with MS. 
In conclusion the results of the current study indicate that 
pain is a common symptom among people with MS. Pain 
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presence was predicted by MS- related disability and fatigue, 
while pain severity was mainly predicted by MS disability. 
The considerable differences between participants with pain 
and those without pain on physical and psychological 
functions highlight the importance of accurate assessment 
and adequate intervention to manage pain in people with 
MS. 
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